Acute arterial thrombosis in the absence of inflammation: The stress-related anti-inflammatory hormone ACTH participates in platelet-mediated thrombosis

Atherosclerosis

Volumn 204, Issue 1, 2009, Pages 79-84

  Pozzi, Aranzazu Ortega ^a   Bernardo, Esther ^a   Coronado, Mónica Torres ^a   Punchard, Marie Anne ^a   González, Pablo ^a   Fantidis, Panayotis ^a  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

Author keywords

Absence of inflammation; ACTH; Acute arterial thrombosis; Platelet aggregation

Indexed keywords

CALCIUM; CORTICOTROPIN; CYCLIC AMP; HYDROCORTISONE; INTERLEUKIN 6; PURINERGIC P2Y RECEPTOR;

ACUTE DISEASE; ANIMAL MODEL; ANIMAL TISSUE; ARTERY THROMBOSIS; ARTICLE; BLOOD VESSEL INJURY; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; COMMON CAROTID ARTERY; CONTROLLED STUDY; EX VIVO STUDY; HORMONE ACTION; IN VIVO STUDY; INFLAMMATION; INHIBITION KINETICS; MODULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RECEPTOR BLOCKING; SWINE; THROMBOCYTE AGGREGATION;

ACUTE DISEASE; ADRENOCORTICOTROPIC HORMONE; ANIMALS; BLOOD PLATELETS; CALCIUM; CAROTID ARTERY INJURIES; CYCLIC AMP; DISEASE MODELS, ANIMAL; HYDROCORTISONE; INFLAMMATION; INJECTIONS, INTRAMUSCULAR; INTERLEUKIN-6; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; RECEPTORS, PURINERGIC P2; SWINE; THROMBOSIS; TIME FACTORS;

EID: 67349095827     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2008.08.023     Document Type: Article

References (30)

1. Virmani R., Burke A., Farb A., and Kolodgie F. Pathology of the vulnerable plaque. J Am Coll Cardiol 47 (2006) C13-C18
2. Monaco A., Mathur A., and Martin J.F. What causes acute coronary syndromes? Applying Koch's postulates. Atherosclerosis 179 (2005) 1-15
3. Gawaz M., Langer H., and May A.E. Platelets in inflammation and atherogenesis. J Clin Invest 115 (2005) 3378-3384
4. Davì G., and Patrono C. Platelet activation and atherothrombosis. N Engl J Med 357 (2007) 2482-2494
5. Liuzzo G., Biasucci L.M., Gallimore J.R., et al. The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina. N Engl J Med 331 (1994) 417-424
6. Liuzzo G., Baisucci L.M., Gallimore J.R., et al. Enhanced inflammatory response in patients with preinfarction unstable angina. J Am Coll Cardiol 34 (1999) 1696-1703
7. Virmani R., Kolodgie F.D., Burke A.P., Farb A., and Schwartz S.M. Lessons from sudden coronary death A comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol 20 (2000) 1262-1275
8. Chrousos G.P. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med 332 (1995) 1351-1362
9. Fantidis P., Perez De Prada T., Fernandez-Ortiz, et al. Morning cortisol production in coronary heart disease patients. Eur J Clin Invest 32 (2002) 304-308
10. Rozanski J.A., Blumenthal K.W., Davidson P.G., Saab P.G., and Kubzansky L. The epidemiology, pathophysiology, and management of psychosocial risk factors in cardiac practice. J Am Coll Cardiol 45 (2005) 637-651
11. Angerer P., Siebert U., Kothny W., Muhlbauer D., Mudra H., and von Schacky C. Impact of social support, cynical hostility and anger expression on progression of coronary atherosclerosis. J Am Coll Cardiol 36 (2000) 781-1788
12. Matthews K.A., Gump B.B., Harris K.F., Haney T.L., and Barefoot J.F. Hostile behaviours predict cardiovascular mortality among men enrolled in the Multiple Risk Factor Intervention Trial. Circulation 109 (2004) 66-70
13. Gidron Y., Gilutz H., Berger R., and Huleihel M. Molecular and cellular interface between behavior and acute coronary syndromes. Cardiovasc Res 56 (2002) 15-21
14. Suarez J.I. Acute myocardial infarction, ischemic stroke, sympathetic stress, and inflammation. Birds of a father. Stroke 37 (2005) 2449-2450
15. Brydon L., Magid K., and Steptoe A. Platelets, coronary heart disease, and stress. Brain Behav Immun 19 (2005) 540-546
16. Strike P.C., and Steptoe A. Behavioural and emotional triggers of acute coronary syndromes: a systematic review and critique. Psychosom Med 67 (2005) 179-186
17. Sabatine S.M. Something old, something new: β blockers and clopidogrel in acute myocardial infarction. Lancet 366 (2005) 1587-1589
18. Van de Graff E., Dutta M., Das P., et al. Early coronary revascularization diminishes the risk of ischemic stroke with acute myocardial infarction. Stroke 37 (2006) 2546-2551
19. COMMIT (Clopidogrel and Metoprolol in Myocardial Infarction Trial) collaborative group. Early intravenous then oral metoprolol in 45852 patients with acute myocardial infarction: randomized placebo-controlled trial. Lancet 2005;366:1622-32.
20. Fantidis P., Pérez De Prada T., Fernández-Ortiz A., et al. Endogenous anti-inflammatory response after coronary injury in a porcine model. Eur J Clin Invest 31 (2001) 1019-1023
21. Chiang T.M., and Zhu J. A defined peptide that inhibits the formation of the glycoprotein IIb and IIIa complex. Thromb Res 115 (2005) 503-508
22. Savi P., Beauverger P., Labouret C., et al. Role of P2Y1 purinoceptor in ADP-induced platelet activation. FEBS Lett 422 (1998) 291-295
23. Malinin A., Pokov A., Swaim L., Kotob M., and Serebruany V. Validation of a VerifyNow-P2Y12 cartridge for monitoring platelet inhibition with clopidogrel. Methods Find Exp Clin Pharmacol 28 (2006) 315-322
24. Fantidis P., Fernández-Ortiz A., Aragoncillo P., et al. Effect of cAMP on the function of endothelial cells and fibromuscular proliferation after the injury of the carotid and coronary arteries in a porcine model. Rev Esp Cardiol 54 (2001) 981-989
25. Labiós M., Martínez F., Gabriel F., Guiral V., Ruiz-Aja S., and Aznar J. Cytoplasmic free calcium mobilization in platelets, expression of P-selectin, phosphatidylserine, and microparticle formation, measured by whole blood flow cytometry, in hypertensive patients. Effect of doxazosin GITS. Thromb Res 117 (2006) 403-409
26. Masi A.T., and Chrousos G.P. Hypothalamic-pituitary-adrenalglucocorticoid axis function in rheumatoid arthritis. J Rheumatol 23 (1996) 577-581
27. Enyeart J.J. Biochemical and ionic signalling mechanisms for ACTH-stimulated cortisol production. Vitam Horm 70 (2005) 265-279
28. Herman A.G., and Herman A.G. Rationale for the combination of anti-aggregating drugs. Thromb Res 92 (1998) S17-S21
29. Gachet C. The platelet P2 receptors as molecular targets for old and new antiplatelet drugs. Pharmacol Ther 108 (2005) 180-192
30. Offermanns S. Activation of platelet function through G protein-coupled receptors. Circ Res 99 (2006) 1293-1304